Delivery of radioligands for positron emission tomography (PET) in the central nervous system

被引:7
|
作者
Tsukada, H [1 ]
机构
[1] Hamamatsu Photon KK, Cent Res Lab, Shizuoka 4348601, Japan
关键词
brain; dopamine; serotonin; neurotransmitter; receptor; transporter; positron emission tomography (PET;
D O I
10.1016/S0169-409X(98)00106-9
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Positron emission tomography (PET) is an imaging technique to monitor the delivery of tracers labeled with positron emitters (C-11, N-13, O-15 and F-18). A wide variety of probes have been labeled to measure biochemical and physiological parameters in the central nervous system (CNS), such as glucose and oxygen metabolism, protein synthesis, blood how, and neurotransmitter receptor functions. The delivery of labeled compounds to the target tissue, which directly reflect the distribution and kinetics patterns, especially to the neurotransmitter receptors is modulated by several factors, such as regional cerebral blood flow (rCBF), peripheral metabolism, and neurotransmitter concentration in the synaptic cleft. These factors provide misunderstanding of the apparent results, which do not reflect the true state of the CNS. The present paper will summarize several factors that affect the delivery of labeled compounds related to the neurotransmitter receptors in the CNS. (C) 1999 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:175 / 188
页数:14
相关论文
共 50 条
  • [1] Positron emission tomography and the central nervous system
    Robinson, RO
    Ferrie, CD
    Capra, M
    Maisey, MN
    ARCHIVES OF DISEASE IN CHILDHOOD, 1999, 81 (03) : 263 - 270
  • [2] Positron emission tomography radioligands for the opioid system
    Dannals, Robert F.
    JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS, 2013, 56 (3-4): : 187 - 195
  • [3] Novel 18F-Labeled Radioligands for Positron Emission Tomography Imaging of Myelination in the Central Nervous System
    Tiwari, Anand Dev
    Zhu, Junqing
    You, Jingqiang
    Eck, Brendan
    Zhu, Jinle
    Wang, Xu
    Wang, Xizhen
    Wang, Bin
    Silver, Jerry
    Wilson, David
    Wu, Chunying
    Wang, Yanming
    JOURNAL OF MEDICINAL CHEMISTRY, 2019, 62 (10) : 4902 - 4914
  • [4] POSITRON EMISSION TOMOGRAPHY OF THE CENTRAL NERVOUS-SYSTEM
    ROTTENBERG, DA
    COOPER, AJL
    TRENDS IN BIOCHEMICAL SCIENCES, 1981, 6 (05) : 120 - 122
  • [5] Differentiation of central nervous system lesions in AIDS patients using positron emission tomography (PET)
    Heald, AE
    Hoffman, JM
    Bartlett, JA
    Waskin, HA
    INTERNATIONAL JOURNAL OF STD & AIDS, 1996, 7 (05) : 337 - 346
  • [6] Positron emission tomography in central nervous system drug discovery and development
    Cooper, M
    Metz, J
    NEUROIMAGING CLINICS OF NORTH AMERICA, 2003, 13 (04) : 851 - +
  • [7] POSITRON EMISSION TOMOGRAPHY IN THE INVESTIGATION OF CENTRAL NERVOUS-SYSTEM DISORDERS
    JAMIESON, D
    ALAVI, A
    JOLLES, P
    CHAWLUK, J
    REIVICH, M
    RADIOLOGIC CLINICS OF NORTH AMERICA, 1988, 26 (05) : 1075 - 1088
  • [8] Role of Positron Emission Tomography in Primary Central Nervous System Lymphoma
    Rozenblum, Laura
    Houillier, Caroline
    Soussain, Carole
    Bertaux, Marc
    Choquet, Sylvain
    Galanaud, Damien
    Hoang-Xuan, Khe
    Kas, Aurelie
    CANCERS, 2022, 14 (17)
  • [9] USEFULNESS OF POSITRON EMISSION TOMOGRAPHY IN THE STUDY OF THE CENTRAL-NERVOUS-SYSTEM
    BERTRAN, JMA
    FROST, JJ
    MEDICINA CLINICA, 1990, 94 (16): : 633 - 636
  • [10] The development of radiotracers for imaging sigma (σ) receptors in the central nervous system (CNS) using positron emission tomography (PET)
    Banister, Samuel D.
    Manoli, Miral
    Kassiou, Michael
    JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS, 2013, 56 (3-4): : 215 - 224